HGYN vs VPRB Stock Comparison

Hong Yuan Holding and VPR Brands Prices as of Oct 23, 2026 Peers: Industry group
HGYN Hong Yuan Holding Group
$0.04 0.0% 1M -20.0% 1Y
Market cap
$2.99M
P/E
–
Revenue (TTM)
$559.73K
Div. yield
–
Food Distribution Consumer Staples
1 win
VPRB VPR Brands, LP.
$0.09 +12.5% 1M +350.0% 1Y
Market cap
$8.26M
P/E
8.2x
Revenue (TTM)
$2.94M
Div. yield
–
Tobacco Consumer Staples
6 wins

Head to Head

7 decided of 12

VPR Brands leads on 6 of the 12 questions below (VPR Brands 6, Hong Yuan Holding 1). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionHGYNVPRBLeader
Larger companyMarket capitalisation $2.99M $8.26M VPRB
Cheaper on earningsLower P/E, profitable companies only -29.9x 8.2x –
Cheaper on forward earningsLower price / next fiscal year consensus EPS — — –
Faster revenue growthRevenue growth, trailing twelve months +6.1% -32.5% HGYN
More profitableNet margin, trailing twelve months -17.9% 34.1% VPRB
Better return on capitalReturn on invested capital — -50.3% –
Less leveragedLower net debt / EBITDA — — –
Higher dividend yieldTrailing dividend yield — — –
Better 1-year returnPrice return, last 12 months -20.0% +350.0% VPRB
Better 5-year returnAnnualised price return, 5 years -27.5%/yr +17.6%/yr VPRB
Less volatileAnnualised volatility, 1 year 349.7% 284.6% VPRB
Higher overall scoreMean of the five percentile scores vs peers 11/100 57/100 VPRB

Percentile Scorecard

HGYNVPRB

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisHGYNVPRB
Valuation 3 #39 of 40 60 #16 of 38
Growth 24 #29 of 38 32 #24 of 35
Profitability 11 #32 of 36 80 #8 of 36
Financial Health 5 #38 of 40 58 #17 of 39
Shareholder Returns – –
Overall 11 57
  • HGYN ranked among 41 companies in Staples Retail
  • VPRB ranked among 40 companies in Tobacco and Cannabis

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodHGYNVPRBSPY
1 month 0.0%+12.5% -0.8%
3 months +33.3%-25.0% +3.5%
6 months -60.0%+350.0% +7.0%
Year to date 0.0%+200.0% +12.2%
1 year -20.0%+350.0% +13.0%
3 years +100.0%-43.8% +86.3%
3 years, per year +26.0%-17.5% +23.1%
5 years -80.0%+125.0% +68.6%
5 years, per year -27.5%+17.6% +11.0%
10 years —-83.6% +258.0%
10 years, per year —-16.6% +13.6%

Risk

MeasureHGYNVPRBSPY
Volatility, 1Y 349.7%284.6% 12.7%
Downside volatility, 1Y 541.5%457.5% 12.7%
Beta vs S&P 500, 1Y 0.24-3.04 1.00
Return / volatility, 1Y -0.061.23 1.02
Max drawdown, 5Y -95.7%-90.9% -25.4%
From 52-week high -73.3%-30.8% -1.8%
52-week high $0.15$0.13 $779.14
52-week low $0.02$0.02 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleHGYNVPRB
P/E now vs peer median -29.9xmedian 22.0x 8.2xmedian 16.5x
P/S now vs peer median 5.3xmedian 0.5x 2.8xmedian 0.9x
EV/EBITDA now vs peer median -33.8xmedian 9.8x —median 12.3x
P/FCF now vs peer median -78.9xmedian 17.8x 5.5xmedian 23.1x
P/B now vs peer median -13.0xmedian 3.0x 7.4xmedian 1.0x
PEG now vs peer median 1.29median 1.18 1.00median 0.56

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsHGYNVPRB
Revenue $559.73K $2.94M
Gross profit $370.82K $737.52K
Operating income -$91.58K -$1.71M
Net income -$99.38K $1.00M
Free cash flow -$37.82K $1.51M
EPS (diluted) $0.00 $0.01
Cash & equivalents $13.37K $2.14M
Total debt – $2.40M
Shares (diluted) 74.64M 91.75M
Enterprise value $3.02M $2.77M

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricHGYNVPRB
P/E -29.9x 8.2x
P/FCF -78.9x 5.5x
P/Operating cash flow -78.9x 5.5x
P/S 5.3x 2.8x
P/B -13.0x 7.4x
P/Tangible book -12.3x 7.8x
EV/EBITDA -33.8x –
EV/EBIT -32.5x -4.0x
EV/Revenue 5.3x 2.3x
EV/FCF -78.6x 4.5x
EV/Operating cash flow -78.6x 4.5x
PEG (3Y EPS CAGR) 1.29 1.00

Growth

14 metrics
MetricHGYNVPRB
Revenue growth (1Y) 6.1% -32.5%
Revenue CAGR (3Y) – -28.2%
Gross profit growth (1Y) 26.9% -38.8%
Gross profit CAGR (3Y) – -33.1%
Operating income growth (1Y) -268.5% -12.3%
Operating income CAGR (3Y) -19.6% -62.2%
Net income growth (1Y) -2,581% 188.4%
Net income CAGR (3Y) -22.9% 6.8%
EPS growth (1Y) -362.0% 188.4%
EPS CAGR (3Y) -23.2% 8.2%
Operating cash flow growth (1Y) 24.4% 767.4%
Operating cash flow CAGR (3Y) – 6.5%
Free cash flow growth (1Y) 24.4% 767.4%
Free cash flow CAGR (3Y) – 6.5%

Profitability

14 metrics
MetricHGYNVPRB
Gross margin 66.2% 25.1%
EBITDA margin -15.7% –
Operating margin -16.4% -58.1%
Pretax margin -16.4% 39.2%
Net margin -17.9% 34.1%
FCF margin -6.8% 51.4%
Operating cash flow margin -6.8% 51.4%
Return on equity – 46.4%
Return on assets -16.4% 16.1%
Return on invested capital – -50.3%
Return on capital employed – -105.1%
Asset turnover 0.9x 0.8x
Cash conversion (OCF / net income) 0.4x 1.5x
Stock comp / revenue – –

Financial Health

11 metrics
MetricHGYNVPRB
Debt / assets – 21.0%
Debt / equity – 0.6x
Net debt / EBITDA – –
Debt / FCF – 0.5x
Liabilities / assets 136.2% 66.7%
Equity / assets -36.2% 33.3%
Interest coverage – -10.1x
Current ratio 0.8x 1.6x
Quick ratio 0.5x 1.3x
Cash ratio 0.0x 1.0x
Altman Z-score -214.31 -1.19

Shareholder Returns

7 metrics
MetricHGYNVPRB
Dividend yield – –
Net buyback yield – –
Shareholder yield – –
Payout ratio (earnings) – –
Payout ratio (FCF) – –
Dividend growth (1Y) – –
Dividend CAGR (3Y) – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusHGYNVPRB

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

HGYNVPRB
HGYN 1.00 0.01
VPRB 0.01 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, HGYN and VPRB?

VPR Brands (VPRB) is the largest by market capitalisation: Hong Yuan Holding (HGYN) $2.99M, VPR Brands (VPRB) $8.26M.

Which company is growing faster?

Hong Yuan Holding (HGYN) grew revenue fastest over the trailing twelve months: Hong Yuan Holding (HGYN) +6.1%, VPR Brands (VPRB) -32.5%.

Which company is more profitable?

VPR Brands (VPRB) has the highest net margin (Hong Yuan Holding (HGYN) -17.9%, VPR Brands (VPRB) 34.1%).

Which stock has performed better?

Over the past year VPR Brands (VPRB) returned the most: Hong Yuan Holding (HGYN) -20.0%, VPR Brands (VPRB) +350.0%. Over five years, VPR Brands (VPRB) compounded fastest (Hong Yuan Holding (HGYN) -27.5%/yr, VPR Brands (VPRB) +17.6%/yr). Returns are price only, before dividends.

Which stock is riskier?

By one-year price volatility, VPR Brands (VPRB) has been the steadiest (Hong Yuan Holding (HGYN) 349.7%, VPR Brands (VPRB) 284.6%). Volatility measures how widely the price swings, not the risk of the business.

Do HGYN and VPRB move together?

Their daily returns over the past year have a correlation of 0.01, a weak relationship. Holding both diversifies more than two closely linked stocks would.

Which is the better stock, HGYN and VPRB?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, VPR Brands (VPRB) leads on 6. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.